6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 4H33
Book a meeting
14
Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
14 Dec 2026 - 16 Dec 2026
stand H2.C84
Book a meeting

Omnicap GmbH

About Omnicap GmbH

We are a professionally managed company serving pharmaceutical industry through an extensive range of pharmaceutical formulations, active ingredients (API's) and excipients. Our team of specialists can accommodate all our clients’ requirements.

As a company dealing with Pharmaceutical products, we work in strict conformity with Swissmedic (Swiss Health Authorities) guidelines and the required level of Good Distribution Practices for medicinal products and active ingredients (GDP) according to Swiss regulations in force.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 4H33
  • CPHI Middle East 2026

    CPHI Middle East 2026

    Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
    14 Dec 2026 - 16 Dec 2026
    stand H2.C84
  • Country/Region:
    Switzerland
  • On CPHI since:
    2017
  • Employees:
    1 - 24
Company types
Pharmaceutical company
Contact info
  • +41786931961
  • Via F.Pelli 13, 6900, Lugano, Lugano, Switzerland
Show contact info Hide contact info

Products from Omnicap GmbH (100)

  • Acetylcysteine & Salt

    Product Acetylcysteine & Salt

    OmniCap GmbH offers a wide range of products which includes Acetylcysteine & Salt. Contact us for more information.
  • Ambroxol hydrochloride

    Product Ambroxol hydrochloride

    Mucolytic and expectorant API that promotes airway mucus clearance and is used in respiratory formulations.
  • Anastrozole

    Product Anastrozole

    Non-steroidal aromatase inhibitor API used in endocrine therapy for hormone-sensitive breast cancer.
  • Ascorbic Acid

    Product Ascorbic Acid

    Vitamin C API and nutritional ingredient used for supplementation, antioxidant activity and correction of vitamin C deficiency.
  • Azacitidine

    Product Azacitidine

    Hypomethylating nucleoside analogue API used as an antineoplastic agent in myelodysplastic syndromes and acute myeloid leukemia.
  • Balsalazide Disodium

    Product Balsalazide Disodium

    Colon-targeted prodrug of mesalazine used as an anti-inflammatory treatment for ulcerative colitis.
  • Bendamustine

    Product Bendamustine

    Alkylating antineoplastic API used in the treatment of selected leukemias and lymphomas.
  • Bicalutamide

    Product Bicalutamide

    Non-steroidal androgen-receptor antagonist API used in hormonal treatment of prostate cancer.
  • Bortezomib

    Product Bortezomib

    Proteasome inhibitor API used in hematologic cancers including multiple myeloma and mantle cell lymphoma.
  • Busulfan

    Product Busulfan

    Alkylating antineoplastic API used in leukemia therapy and conditioning regimens before hematopoietic stem-cell transplantation.
  • Cabazital

    Product Cabazital

    Taxane-class microtubule inhibitor API used in oncology, particularly for advanced prostate cancer.
  • Cabergoline

    Product Cabergoline

    Long-acting dopamine D2 receptor agonist API used primarily to reduce elevated prolactin levels.
show all 100 products